View : 266 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author김윤환*
dc.date.accessioned2024-02-01T16:30:47Z-
dc.date.available2024-02-01T16:30:47Z-
dc.date.issued2024*
dc.identifier.issn2005-0380*
dc.identifier.otherOAK-34791*
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/266922-
dc.description.abstractSince the latest practice guidelines for ovarian cancer were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2021, many studies have examined the efficacy and safety of various treatments for epithelial ovarian cancer (EOC). Therefore, the need to develop recommendations for EOC treatments has been raised. This study searched the literature using 4 key items and the Population, Intervention, Comparison, and Outcome: the efficacy and safety of poly-ADP ribose polymerase inhibitors in newly diagnosed advanced EOC; the efficacy and safety of intraperitoneal plus intravenous chemotherapy in optimally debulked advanced EOC; the efficacy and safety of secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer; and the efficacy and safety of the addition of bevacizumab to platinum-based chemotherapy in first platinum-sensitive recurrent EOC patients who received prior bevacizumab. The evidence for these recommendations, according to each key question, was evaluated using a systematic review and meta-analysis. The committee of ovarian cancer of the KSGO developed updated guidelines for treatments of EOC. © 2024. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology.*
dc.languageEnglish*
dc.publisherKorean Society of Gynecologic Oncology and Colposcopy*
dc.subjectBevacizumab*
dc.subjectCytoreductive Surgery*
dc.subjectEpithelial Ovarian Cancer*
dc.subjectIntraperitoneal Chemotherapy*
dc.subjectPoly (ADP-ribose) Polymerase Inhibitor*
dc.subjectSurvival*
dc.titleClinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines*
dc.typeArticle*
dc.relation.issue1*
dc.relation.volume35*
dc.relation.indexSCIE*
dc.relation.indexSCOPUS*
dc.relation.indexKCI*
dc.relation.journaltitleJournal of Gynecologic Oncology*
dc.identifier.doi10.3802/jgo.2024.35.e43*
dc.identifier.scopusid2-s2.0-85182590051*
dc.author.googleLee*
dc.author.googleBanghyun*
dc.author.googleChang*
dc.author.googleSuk-Joon*
dc.author.googleKwon*
dc.author.googleByung Su*
dc.author.googleSon*
dc.author.googleJoo-Hyuk*
dc.author.googleLim*
dc.author.googleMyong Cheol*
dc.author.googleKim*
dc.author.googleYun Hwan*
dc.author.googleShin-Wha*
dc.author.googleChoi*
dc.author.googleChel Hun*
dc.author.googleEoh*
dc.author.googleKyung Jin*
dc.author.googleJung-Yun*
dc.author.googleSuh*
dc.author.googleDong Hoon*
dc.author.googleYong Beom*
dc.contributor.scopusid김윤환(55763947200)*
dc.date.modifydate20240502145036*
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE